Governance and Stakeholder Engagement as Tools for Advancing Clinical Research Excellence

Enginee ing and Technology Jou nal e-ISSN: 2456-3358
Volume 10 Issue 10 Oc obe -2025, Page No.-7296-7317
DOI: 10.47191/e j/ 10i10.10, I.F. – 8.482
© 2025, ETJ
7296
ETJ Volume 10 Issue 10 Oc obe 2025,
1
Chisom Ezeanochie
Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical
Resea ch Excellence
Chisom Ezeanochie1, Opeoluwa Oluwani emi Akomola e2, Ch is iana Adeyemi3
1IQVIA/MSD, UK
2Independen Resea che , UK
3Bluebonne Medical Rehabili a ion Hospi al - Nu se, Texas, USA
ABSTRACT: Go e nance and s akeholde engagemen a e inc easingly ecognized as c i ical enable s o clinical esea ch
excellence, pa icula ly in complex, mul i-ins i u ional, and global en i onmen s. Robus go e nance s uc u es p o ide he s a egic
o e sigh , accoun abili y mechanisms, and ope a ional amewo ks necessa y o ensu e anspa ency, compliance, and e hical
in eg i y in clinical esea ch. A he same ime, meaning ul engagemen o di e se s akeholde s including pa ien s, ca egi e s,
in es iga o s, egula o s, indus y sponso s, and communi y ep esen a i es enhances he ele ance, inclusi i y, and sus ainabili y
o esea ch ini ia i es. Toge he , hese complemen a y ools c ea e an ecosys em ha os e s us , accele a es inno a ion, and
ele a es he quali y o scien i ic ou comes. E ec i e go e nance in clinical esea ch in ol es clea de ini ion o oles, s eamlined
decision-making p ocesses, ha monized policies, and isk-based moni o ing app oaches. By implemen ing s anda dized ope a ing
p ocedu es, single ins i u ional e iew boa d (IRB) models, and anspa en epo ing amewo ks, go e nance sys ems educe
duplica ion, minimize delays, and s eng hen egula o y compliance. Fu he mo e, adap i e go e nance models allow esea ch
conso ia o emain esponsi e o eme ging e idence, e ol ing egula ions, and shi s in socie al expec a ions, he eby ein o cing
esilience and long- e m iabili y. S akeholde engagemen complemen s go e nance by cen e ing he pa ien and communi y oice
in esea ch design, implemen a ion, and dissemina ion. Engaging s akeholde s ea ly h ough ad iso y boa ds, co-design wo kshops,
and pa ien na iga ion p og ams ensu es ha s udy p o ocols e lec cul u al sensi i i y, e hical esponsibili y, and p ac ical
easibili y. Simila ly, collabo a ion wi h egula o s and sponso s enhances ial e iciency, while pa ne ships wi h communi y
o ganiza ions b oaden ou each and p omo e equi able access o pa icipa ion. These engagemen p ac ices no only inc ease
ec ui men and e en ion bu also s eng hen public us in clinical esea ch as a socially esponsi e en e p ise. By in eg a ing
go e nance and s akeholde engagemen as s a egic le e s, clinical esea ch ne wo ks can imp o e da a quali y, ope a ional
e iciency, and e hical s anda ds, while d i ing inno a ion in he apeu ic disco e y. The esul is a mo e accoun able, inclusi e, and
pa ien -cen e ed esea ch en i onmen ha ad ances excellence and con ibu es o global heal h impac .
KEYWORDS: go e nance, s akeholde engagemen , clinical esea ch, esea ch excellence, pa ien -cen e ed esea ch, egula o y
compliance, e hics, anspa ency, communi y engagemen , inno a ion.
1.0. INTRODUCTION EXECUTIVE SUMMARY &
RATIONALE
Clinical esea ch excellence depends no only on scien i ic
igo bu also on he sys ems o go e nance and he s eng h
o s akeholde engagemen ha sus ain i . Ye mul i-si e and
mul i-ins i u ional ials equen ly encoun e challenges ha
comp omise bo h e iciency and c edibili y. Va iabili y
ac oss si es in ope a ional s anda ds, inconsis en applica ion
o e hical p o ocols, delays in egula o y app o al, and gaps
in pa ien and communi y us all combine o slow p og ess.
Inequi ies in ec ui men and pa icipa ion u he weaken he
gene alizabili y o esul s, unde mining he e y pu pose o
clinical esea ch: o gene a e knowledge ha bene i s all
popula ions equi ably (Odugbose, Adegoke & Adeyemi,
2024, Osi owokan & Adukpo, 2024). These challenges
highligh he u gen need o go e nance amewo ks and
s akeholde engagemen models ha mo e beyond
compliance o become ac i e enable s o quali y, inclusi i y,
and ep oducibili y.
The ision o mode n clinical esea ch go e nance is an
ecosys em ha is accoun able, anspa en , and pa ien -
cen e ed. Go e nance s uc u es mus p o ide o e sigh
wi hou igidi y, ensu ing compliance while enabling
inno a ion. A he same ime, s akeholde engagemen mus
mo e beyond oken inclusion o ac i e collabo a ion, whe e
pa ien s, ca egi e s, egula o s, clinicians, sponso s, and
communi y ep esen a i es co-c ea e esea ch pa hways.
Toge he , hese elemen s os e a clima e o us ,
esponsi eness, and equi y, ensu ing ha clinical ials a e no
only echnically success ul bu also socially meaning ul. This
ision shi s go e nance and engagemen om being
pe cei ed as bu eauc a ic obliga ions o being ecognized as
“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7297
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
he s a egic le e s ha accele a e disco e y and ampli y
impac (Akinbode & Taiwo, 2025, Bha adwaj Pa asa am,
2025, Taiwo, 2025, Muneses, 2025).
The objec i es o his app oach a e clea : o enhance quali y,
accele a e speed, expand inclusi i y, s eng hen
ep oducibili y, and build du able public us . Quali y is
achie ed when go e nance ha monizes p ocesses and
educes a iabili y ac oss si es. Speed comes om
s eamlined o e sigh and ac i e s akeholde collabo a ion
ha minimizes delays and maximizes e iciency. Inclusi i y
is d i en by delibe a e engagemen o unde ep esen ed
g oups and communi ies, embedding di e si y in o ial
design and execu ion (Giwah, e al., 2021, Oluyemi,
Akin imehin & Akomola e, 2021). Rep oducibili y is ensu ed
h ough anspa ency, s anda diza ion, and sha ed
accoun abili y ac oss ins i u ions. Public us is ea ned when
pa icipan s and communi ies see hei alues e lec ed in
esea ch p ocesses and ou comes. Toge he , hese objec i es
de ine a pa hway o ad ancing clinical esea ch excellence
by embedding go e nance and s akeholde engagemen a he
hea o inno a ion (Adeyemo, 2025, Ha e lach, e al., 2025,
Taiwo and Busa i, 2025).
2.1. Me hodology
The s udy adop s a mixed-me hods, quali y-by-design
app oach ha in eg a es s akeholde co-c ea ion, isk-based
o e sigh , and da a-d i en lea ning o ad ance clinical
esea ch excellence. Fi s , a go e nance cha e is es ablished
wi h he sponso and coo dina ing cen e o de ine aims,
scope, da a igh s, equi y p inciples, oles, and escala ion
pa hways, including an independen o e sigh body o sa e y
and da a in eg i y. This cha e encodes quali y-by-design
con ols de i ed om isk-based moni o ing li e a u e and
cen al s a is ical moni o ing (Ag a io is e al., 2018; Ba nes
e al., 2021; Adams e al., 2023), and i commi s o
pa icipa o y p inciples om good-pa icipa o y-p ac ice and
mul is akeholde ne wo ks so ha pa ien s, communi ies,
si es, egula o s, and indus y pa ne s a e engaged om
p io i iza ion h ough dissemina ion (Selby e al., 2018;
Boye e al., 2018; Goba e al., 2025). Nex , a s uc u ed
con ex scan and s akeholde mapping is pe o med o
iden i y ac o s, incen i es, capaci y cons ain s, and
egula o y ouchpoin s, including LMIC-speci ic ba ie s and
si e eadiness issues obse ed in global ials (Alemayehu e
al., 2018; Smi h e al., 2019). This mapping in o ms
ec ui men , e en ion, and biospecimen wo k lows,
supplemen ed by si e men o ing and winning models ha
ha e demons a ed imp o emen s in acc ual and ope a ional
eliabili y (Johnson e al., 2018; Hopkins e al., 2013; Beck e
al., 2020).
Digi al and da a enablemen p oceeds in pa allel o ensu e
ha he engagemen plan is ope a ionalizable. Elec onic
consen , ePRO, and egis y linkages a e con igu ed on
in e ope able pla o ms wi h usabili y sa egua ds o p o ec
in o ma ion in eg i y and educe wo k-a ounds ha can e ode
da a quali y (Middle on e al., 2013; Bowman, 2013). Da a
s ewa dship ollows FAIR and p i acy-by-design no ms,
while explainable-AI gua d ails a e in oduced anywhe e
machine lea ning suppo s decision-making o balance
accu acy wi h in e p e abili y and isk awa eness (Ozdemi ,
2024; Zhang e al., 2022). To educe p e en able e o s and
s eng hen sa e y cul u e, pa ien -sa e y e en axonomies
and nea -miss epo ing a e embedded, complemen ed by
eadiness checks o AE/SAE imeliness and p o ocol
adhe ence (Chang e al., 2005; Gong e al., 2017; Ho mann
& Rohe, 2010). Equi y is ea ed as a non-nego iable quali y
a ibu e; he ope a ing plan speci ies ep esen a ion
h esholds and cul u ally adap ed ma e ials, d awing on
e idence o inclusi e e en ion and sus ained ou comes
(Hend icks-Fe guson e al., 2013; Haw e al., 2017; Hamil on
& Yano, 2017).
Risk iden i ica ion and o e sigh combine p ospec i e isk
assessmen wi h cen al moni o ing and anomaly de ec ion.
T ial- and si e-le el isk egis e s a e sco ed ac oss da a
quali y, sa e y, consen , eligibili y, and ope a ional domains.
Cen al s a is ical moni o ing sc eens o a ypical pa e ns
(e.g., digi p e e ence, ou lie s, ex eme p o ocol iming) ha
igge a ge ed on-si e o emo e e iew, and isk signals
in o m adap i e moni o ing in ensi y (Hu ley e al., 2016;
Timme mans e al., 2016; Higa e al., 2020; Diani e al.,
2017). This isk engine is ex ended o imaging and
bioma ke -d i en oncology s udies whe e mis-speci ica ion
isks a e ma e ial (Liu e al., 2015). Si es ecei e playbooks,
compe ency checks, and men o ing cu icula; mobile
ec ui men and communi y pa ne ships a e deployed o
educe access ba ie s and suppo di e se acc ual (Goodle
e al., 2020; Beck e al., 2020). Capaci y-building
inco po a es men o ed implemen a ion and communi ies o
p ac ice o close pe o mance gaps o e ime, aligning wi h
bes p ac ice o esea ch capaci y s eng hening in a ied
se ings (Asampong e al., 2023; Kaba e al., 2023; Bu gess
& Cha away, 2021).
Measu emen and lea ning a e s uc u ed a ound a anspa en
indica o amewo k acked in nea - eal ime. Leading and
lagging indica o s include ime- o-IRB and si e ac i a ion,
sc eening- o-en ollmen con e sion, de ia ion densi y and
ecu ence, que y a es pe 100 CRFs, AE/SAE epo ing
imeliness, audi ou comes, and ePRO comple ion.
Engagemen me ics co e pa icipan di e si y, e en ion,
sa is ac ion, communi y mee ing cadence, and s akeholde
NPS; si e- acing measu es add s a compe ency p og ession
and men o ing ouchpoin s. Dashboa ds implemen cen al
e iew and ale ing, and indings a e benchma ked ac oss
si es and s udy phases o guide esou ce alloca ion (K
Gohagan e al., 2015; Falade e al., 2024). A o mal CAPA
engine links oo -cause analyses o co ec i e and p e en i e
ac ions, wi h changes e i ied h ough A/B es s o s epped-
wedge pilo s whe e easible, hen codi ied in o SOPs and
playbooks. Lessons lea ned popula e a sea chable lib a y o
accele a e o ganiza ional lea ning and educe ime- o-
“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7298
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
compe ency o new eams (F iedman e al., 2015; Bha ,
2011).
E hics and compliance a e in eg a ed h oughou . The
go e nance cha e cons ains da a uses, ensu es clea
communi y bene i -sha ing o co-c ea ed knowledge, and
manda es anspa en epo ing o pa icipan s and
communi ies. Fo AI-enabled modules, documen a ion o
model pu pose, da a lineage, pe o mance by subg oup, and
human-in- he-loop bounda ies add esses common pi alls in
clinical ML, while usabili y e alua ions p e en sa e y-
c i ical EHR in e ac ions om in oducing e o (Doyen &
Dada io, 2022; Middle on e al., 2013). The dissemina ion
s a egy includes pa ien - acing summa ies, open me hods
whe e app op ia e, and policy b ie s o suppo egula o y
science and p ac ice up ake (C uz Ri e a e al., 2021; Zineh
& Woodcock, 2013). Sus ainabili y planning quan i ies he
ROI o go e nance (e.g., delay a oidance, audi isk
educ ion) and di e si ies unding o sus ain engagemen
in as uc u e beyond a single s udy. Th oughou , his me hod
keeps go e nance and s akeholde engagemen as ope a ional
ools no jus delibe a i e p ocesses deli e ing measu able
gains in da a quali y, sa e y, equi y, and speed.
Figu e 1: Flowcha o he s udy me hodology
2.2. Go e nance F amewo k & P inciples
Go e nance amewo ks in clinical esea ch se e as he
s uc u al ounda ion ha de e mines whe he inno a ions in
s akeholde engagemen and ope a ional design ansla e in o
consis en excellence ac oss mul iple si es. Wi hou obus
go e nance, ials isk agmen a ion, delays, and e hical
lapses. The mos e ec i e amewo ks a e hose ha wea e
oge he co e p inciples o good go e nance, align wi h
in e na ional egula o y s anda ds, and ope a ionalize hei
alues h ough conc e e a i ac s such as cha e s, policies,
RACI ma ices, and decision-making ools. Toge he , hese
componen s c ea e a sys em o o e sigh ha is igo ous ye
lexible, pa ien -cen e ed ye scien i ically sound, and
anspa en ye e icien (Adeyemi, e al., 2022, C acowski, e
al., 2022, Oladeinde, e al., 2022).
The co e p inciples ha de ine a s ong go e nance
amewo k a e accoun abili y, anspa ency, equi y,
p opo ionali y, and quali y by design (QbD). Accoun abili y
ensu es ha e e y ac o in he ial ecosys em is esponsible
o hei ac ions, wi h clea mechanisms o o e sigh ,
epo ing, and co ec ion. This p e en s ambigui y in oles
and p omo es eliabili y ac oss si es. T anspa ency goes hand
in hand wi h accoun abili y, ensu ing ha decisions,
p ocesses, and ou comes a e isible o s akeholde s, including
pa ien s and communi ies. T anspa ency builds us , which
is essen ial in clinical esea ch whe e pa icipa ion elies on
indi iduals sha ing sensi i e in o ma ion and subjec ing
hemsel es o in es iga ional he apies (Giwah, e al., 2020,
Oluyemi, Akin imehin & Akomola e, 2020). Equi y ensu es
ha go e nance s uc u es and ial p ocesses p omo e
ai ness and inclusi i y, add essing sys emic ba ie s ha
o en exclude mino i y and unde se ed popula ions om
esea ch. P opo ionali y ensu es ha go e nance
equi emen s a e ma ched o he isks in ol ed; o e ly
bu densome o e sigh can slow ials wi hou adding
p o ec ion, while insu icien o e sigh isks ha m
(Akinbode, Taiwo & Uchenna, 2023, Zhang, e al., 2023).
Finally, he p inciple o quali y by design embeds o esigh
in o go e nance, equi ing ha isks o da a in eg i y, pa ien
sa e y, and inclusi i y a e an icipa ed and mi iga ed du ing
he planning s age a he han co ec ed e ospec i ely.
Toge he , hese p inciples c ea e a cul u e whe e go e nance
is no simply abou compliance bu abou ac i ely enabling
excellence. Figu e 2 shows clinical go e nance
implemen a ion: undamen al componen s and ela ionships
wi h o ganiza ional s uc u e p esen ed by Co ao, e al.,
2008.
Figu e 2: Clinical go e nance implemen a ion:
undamen al componen s and ela ionships wi h
o ganiza ional s uc u e (Co ao, e al., 2008).
“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7299
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
Alignmen wi h egula ions and in e na ional s anda ds
p o ides legi imacy and en o ceabili y o go e nance
amewo ks. Good Clinical P ac ice (GCP) guidelines emain
he gold s anda d, es ablishing e hical and scien i ic quali y
benchma ks o ials in ol ing human pa icipan s.
Adhe ence o GCP ensu es ha pa ien igh s a e espec ed,
da a a e c edible, and ial p ocesses a e scien i ically sound.
Fo s udies in ol ing digi al ools and elec onic da a cap u e,
compliance wi h 21 CFR Pa 11 in he Uni ed S a es is
essen ial. This egula ion ensu es ha elec onic eco ds and
signa u es a e us wo hy, eliable, and equi alen o pape
eco ds, sa egua ding bo h au hen ici y and in eg i y. In
con ex s whe e pa ien p i acy is pa amoun , he Heal h
Insu ance Po abili y and Accoun abili y Ac (HIPAA) in he
U.S. and he Gene al Da a P o ec ion Regula ion (GDPR) in
he Eu opean Union p o ide amewo ks o p o ec ing
sensi i e heal h da a (Adeyemi, e al., 2023, Hungbo,
Adeyemi & Ajayi, 2023). These egula ions equi e s ingen
sa egua ds such as ole-based access, enc yp ion, and de-
iden i ica ion, which a e c i ical in mul i-si e ials whe e da a
c oss ins i u ional and some imes na ional bounda ies. The
In e na ional Council o Ha monisa ion’s E6(R3) guideline
u he ex ends go e nance alignmen by p o iding upda ed
guidance on GCP ha e lec s mode n echnologies and isk-
based app oaches. Toge he , hese egula o y ancho s ensu e
ha go e nance amewo ks a e no only e hically obus bu
also legally complian ac oss di e se ju isdic ions (Timmis,
2021, Wilkins, e al., 2021).
The p ac ical exp ession o go e nance lies in i s a i ac s
documen s and ools ha codi y p inciples and p o ide
ope a ional cla i y. Cha e s se e as ounda ional
documen s, de ining he au ho i y, scope, and esponsibili ies
o go e nance bodies such as s ee ing commi ees, da a sa e y
moni o ing boa ds, and di e si y ad iso y councils. Policies
ansla e p inciples in o ac ionable ules, se ing expec a ions
o a eas such as con lic o in e es managemen , da a
p i acy, communi y engagemen , and equi y in ec ui men .
A RACI (Responsible, Accoun able, Consul ed, In o med)
ma ix u he ope a ionalizes accoun abili y by cla i ying
who is esponsible o asks, who is accoun able o
ou comes, who mus be consul ed, and who should be kep
in o med (Enna & Williams, 2009, Hungbo & Adeyemi,
2019, Olaniyan, e al., 2018). This ool minimizes con usion,
p e en s duplica ion, and ensu es ha c i ical asks a e no
o e looked. Decision ma ices p o ide s uc u ed me hods
o e alua ing op ions and eaching consensus, pa icula ly in
complex scena ios such as balancing pa ien sa e y wi h ial
con inui y o deciding on p o ocol amendmen s
(Muyassa o a & Bol aboye , 2025, Paul, 2025, Pe e , 2025).
By p o iding cla i y, consis ency, and anspa ency, hese
a i ac s ans o m abs ac p inciples in o p ac ical guidance
ha si e s a , in es iga o s, and o e sigh commi ees can
apply daily. Figu e 3 shows s akeholde engagemen p ocess
o esea ch planning and implemen a ion in he con ex o
Heal h E ec s Ins i u e Ene gy's b oade model o p o iding
impa ial, policy‐ ele an science p esen ed by Roso sky &
Vo hees, 2023.
Figu e 3: S akeholde engagemen p ocess o esea ch
planning and implemen a ion in he con ex o Heal h
E ec s Ins i u e Ene gy's b oade model o p o iding
impa ial, policy‐ ele an science (Roso sky & Vo hees,
2023).
The in eg a ion o p inciples, egula o y s anda ds, and
go e nance a i ac s c ea es a amewo k ha ac i ely d i es
excellence. Accoun abili y and anspa ency ensu e ha
go e nance p ocesses a e c edible and us ed by
s akeholde s. Equi y ensu es ha ials ec ui and e ain
di e se pa icipan s, making esul s mo e gene alizable and
e hically sound. P opo ionali y balances o e sigh wi h
e iciency, p e en ing go e nance om becoming a ba ie o
inno a ion (A ihyia , e al., 2025, Lakshmi P iya & De i,
2025, Olaniyan, e al., 2025). Quali y by design ensu es ha
go e nance an icipa es isks and embeds sa egua ds om he
ou se . Alignmen wi h GCP, 21 CFR Pa 11, HIPAA,
GDPR, and ICH guidelines ensu es ha go e nance is
globally espec ed and locally en o ceable. Cha e s, policies,
RACI ma ices, and decision ools p o ide he ope a ional
backbone o apply hese p inciples consis en ly ac oss si es.
The downs eam e ec o his in eg a ed go e nance
amewo k is a esea ch ecosys em ha is accoun able,
anspa en , pa ien -cen e ed, and capable o p oducing high-
quali y, ep oducible e idence. Va iabili y ac oss si es is
educed because policies and RACI ma ices p o ide
consis en expec a ions. Delays a e minimized because
decision ma ices s eamline complex choices and
p opo ionali y p inciples p e en unnecessa y bu eauc acy.
T us gaps a e add essed h ough anspa ency, equi y, and
cha e s ha o malize pa ien and communi y pa icipa ion
in go e nance bodies. Inequi ies a e ac i ely coun e ed by
embedding equi y as a go e nance p inciple and moni o ing
i h ough o mal policies and epo ing (Haw, e al., 2017,
Hu ley, e al., 2016, Hu ley, e al., 2018).
“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7300
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
In conclusion, go e nance amewo ks oo ed in
accoun abili y, anspa ency, equi y, p opo ionali y, and
quali y by design a e indispensable ools o ad ancing
clinical esea ch excellence. Thei alignmen wi h
in e na ional egula o y s anda ds ensu es e hical and legal
obus ness, while go e nance a i ac s such as cha e s,
policies, RACI ma ices, and decision ools p o ide he
ope a ional cla i y necessa y o consis en applica ion.
Toge he , hese elemen s c ea e a sys em o go e nance ha
does mo e han en o ce compliance; i enables inno a ion,
p o ec s pa icipan s, builds us , and ensu es ha clinical
esea ch is bo h scien i ically igo ous and socially
meaning ul. This in eg a ion o p inciples, s anda ds, and
p ac ice de ines he pa hway owa d clinical esea ch sys ems
ha a e esilien , equi able, and capable o sus aining
excellence in an e a o inc easing complexi y and global
collabo a ion (Adeyemo, Mba a & Balogun, 2024, Hungbo &
Adeyemi, 2024, Ozdemi , 2024).
2.3. S uc u es, Roles & Decision Righ s
S uc u es, oles, and decision igh s wi hin go e nance
amewo ks de ine how au ho i y, accoun abili y, and
esponsibili y a e dis ibu ed in clinical esea ch. In mul i-si e
cance s udies and o he complex clinical ials, hese
componen s de e mine whe he go e nance p inciples
ansla e in o consis en , ac ionable ou comes. Wi hou
clea ly de ined s uc u es, ials a e ulne able o
agmen a ion, ine iciency, and e hical lapses. Con e sely,
when go e nance bodies, ope a ional oles, and decision-
making pa hways a e codi ied and espec ed, esea ch
ecosys ems achie e bo h scien i ic igo and s akeholde us
(Adegoke, Odugbose & Adeyemi, 2024, Kabi , Rana &
Debna h, 2024).
The key go e nance bodies in his ecosys em a e he S ee ing
Commi ee, Scien i ic Commi ee, Da a Sa e y Moni o ing
Boa d (DSMB) o Da a Moni o ing Commi ee (DMC), and
he Single Ins i u ional Re iew Boa d (IRB). The S ee ing
Commi ee unc ions as he cen al decision-making
au ho i y, se ing s a egic di ec ion, ensu ing p o ocol
compliance, and p o iding o e sigh o ope a ional
pe o mance ac oss si es. I embodies he p inciple o
accoun abili y by holding all ac o s o sha ed s anda ds, while
also enabling coo dina ion ac oss di e se ins i u ions. The
Scien i ic Commi ee p o ides specialized expe ise,
ensu ing ha s udy design, da a in e p e a ion, and
publica ion p ac ices mee he highes scien i ic s anda ds
(Adeyemi, Adegoke & Odugbose, 2024, Bonaconsa, e al.,
2024, P asanna, Ko hapalli & Vasan han, 2024). This
commi ee ensu es ha pa ien -cen e ed inno a ions in
ec ui men and e en ion a e no only ope a ionally easible
bu also me hodologically obus . The DSMB o DMC
ope a es independen ly, sa egua ding pa ien sa e y and ial
in eg i y. By e iewing ad e se e en da a, in e im analyses,
and oxici y managemen , he DSMB ensu es ha pa icipan
wel a e emains pa amoun . The Single IRB, meanwhile,
ha monizes e hical e iew ac oss mul iple si es, educing
delays and a iabili y while ensu ing consis en p o ec ion o
pa ien igh s. Collec i ely, hese bodies o m a laye ed
s uc u e ha balances s a egic o e sigh , scien i ic igo ,
pa ien sa e y, and e hical in eg i y. Figu e 4 shows he igu e
o s akeholde engagemen p esen ed by Sanka , e al., 2024.
Figu e 4: S akeholde engagemen (Sanka , e al., 2024).
Ope a ional oles b ing hese go e nance s uc u es o li e.
Sponso s ca y he ul ima e esponsibili y o he ini ia ion,
managemen , and inancing o ials. They se p io i ies,
p o ide esou ces, and ensu e alignmen wi h egula o y
amewo ks. Con ac Resea ch O ganiza ions (CROs) o en
se e as ope a ional pa ne s, ansla ing sponso di ec i es
in o si e-le el ac i i ies and ensu ing compliance h ough
moni o ing, aining, and quali y assu ance. P incipal
In es iga o s (PIs) and Sub-In es iga o s (Sub-Is) lead si e-
le el execu ion, managing pa ien in e ac ions, da a
collec ion, and adhe ence o p o ocols (A o a, Mau ya &
Kacke , 2017, Uwai o & John-Ohimai, 2020). Thei ole
embodies accoun abili y o bo h go e nance bodies and
pa icipan s, as hey a e di ec ly esponsible o he ideli y o
ial conduc . Da a S ewa ds ensu e ha in o ma ion is
accu a e, comple e, and consis en ac oss sys ems, while
P i acy O ice s gua an ee compliance wi h egula ions such
as HIPAA and GDPR, ensu ing sensi i e pa ien in o ma ion
is p o ec ed. Pa ien Ad iso s play a c i ical and inc easingly
ecognized ole, embedding li ed expe ience in o go e nance
delibe a ions. Thei insigh s ensu e ha ec ui men and
e en ion s a egies, as well as b oade ial p ac ices, e lec
pa ien needs and expec a ions. Toge he , hese ope a ional
oles dis ibu e esponsibili y ac oss he ecosys em, ensu ing
ha no single poin o ailu e unde mines ial quali y
(A oba ele, Hungbo & Adeyemi, 2019, Olaniyan, Uwai o &
Ojedi an, 2019).
Clea escala ion pa hways, con lic esolu ion mechanisms,
and change con ol p ocesses p o ide he glue ha holds
go e nance oge he . Escala ion pa hways de ine how issues
a e aised, e alua ed, and add essed when p oblems exceed
he au ho i y o local si e s a . Fo example, an unexpec ed
spike in ad e se e en s a one si e may i s be escala ed o
he PI, hen o he S ee ing Commi ee, and inally o he

“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7301
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
DSMB i sys emic sa e y conce ns a e suspec ed. Con lic
esolu ion p ocesses ensu e ha disag eemen s whe he
be ween in es iga o s, si es, o go e nance bodies a e
handled anspa en ly and ai ly (Adams, e al., 2023,
Epi ano, 2023, Musyuni, Sha ma & Agga wal, 2023). These
p ocesses p e en delays and ein o ce us among
s akeholde s. Change con ol mechanisms o malize how
modi ica ions o p o ocols, p ocedu es, o go e nance
s uc u es a e p oposed, e iewed, and implemen ed. By
equi ing documen ed jus i ica ion, impac assessmen , and
app o al om ele an bodies, change con ol ensu es ha
adjus men s enhance a he han comp omise ial in eg i y.
These mechanisms embody he go e nance p inciples o
anspa ency and p opo ionali y, ensu ing ha decisions a e
aceable and aligned wi h pa ien sa e y and scien i ic
alidi y (Akin imehin, e al., 2025, Kunle & Taiwo, 2025,
Taiwo, Ola unji & Akomola e, 2025).
The in eg a ion o go e nance bodies, ope a ional oles, and
decision-making p ocesses c ea es a esea ch en i onmen
ha is bo h esilien and adap able. S a egic o e sigh by he
S ee ing Commi ee and Scien i ic Commi ee ensu es ha
inno a ions a e aligned wi h ial objec i es. Independen
sa e y moni o ing by he DSMB p o ec s pa icipan s while
main aining c edibili y wi h egula o s. E hical o e sigh by
he Single IRB ha monizes p o ec ions ac oss si es, enabling
as e and mo e consis en ial execu ion. Sponso s, CROs,
in es iga o s, da a s ewa ds, p i acy o ice s, and pa ien
ad iso s dis ibu e ope a ional esponsibili ies, ensu ing bo h
echnical igo and pa ien -cen e edness (Fneish,
Schaa schmid & Fo wengel, 2021). Escala ion, con lic
esolu ion, and change con ol c ea e mechanisms o
managing unce ain y, p e en ing b eakdowns, and enabling
adap i e esponses o eme ging challenges.
When implemen ed e ec i ely, hese s uc u es educe
a iabili y ac oss si es, accele a e imelines, and build du able
public us . They ensu e ha ec ui men and e en ion
inno a ions such as digi al ools, communi y pa ne ships,
and equi y suppo s a e applied consis en ly, e hically, and
e ec i ely. Pa ien s see go e nance as a sa egua d o hei
igh s and digni y, while in es iga o s and s a expe ience
cla i y in hei oles and esponsibili ies. Sponso s and
egula o s gain con idence in he eliabili y and
ep oducibili y o ou comes. Ul ima ely, go e nance
s uc u es, oles, and decision igh s ans o m clinical
esea ch om a agmen ed se o local ac i i ies in o a
cohesi e, accoun able sys em capable o ad ancing
excellence on a na ional and global scale (Adeyemo, 2025,
De oy, e al., 2025, Taiwo, e al., 2025).
2.4. S akeholde Mapping & Engagemen S a egy
S akeholde mapping and engagemen s a egy o m he
ela ional backbone o go e nance in clinical esea ch. No
ma e how obus he egula o y amewo ks, scien i ic
p o ocols, o da a sys ems a e, clinical s udies ul ima ely
depend on people pa ien s who consen o pa icipa e,
ca egi e s who suppo hem, in es iga o s and s a who
deli e in e en ions, egula o s who en o ce s anda ds,
sponso s and paye s who und ac i i ies, and communi y
o ganiza ions ha os e us and accessibili y. To ad ance
clinical esea ch excellence, go e nance amewo ks mus
map hese s akeholde s clea ly, design inclusi e and e ec i e
engagemen s a egies, and deploy equi y le e s ha add ess
sys emic ba ie s o pa icipa ion (Hopkins, Bu ns & Eden,
2013, K Gohagan, e al., 2015, Obodozie, 2012). By doing so,
ials become no only scien i ically igo ous bu also socially
legi ima e, sus ainable, and equi able.
The s akeholde landscape in clinical esea ch is di e se and
mul i-laye ed. Pa ien s and ca egi e s si a he cen e , as he
p ima y con ibu o s o da a and he popula ion mos di ec ly
a ec ed by ou comes. Thei willingness o en oll, s ay
engaged, and p o ide hones eedback de e mines he
easibili y and alidi y o ials. Ca egi e s, o en o e looked,
a e c i ical in managing logis ics, ensu ing adhe ence, and
o e ing psychosocial suppo . Clinical si es, including
academic cen e s and communi y p ac ices, se e as he
ope a ional in e ace be ween p o ocols and pa ien s.
Regula o s p o ide o e sigh o p o ec pa icipan igh s and
ensu e compliance wi h e hical and scien i ic s anda ds
(Oladeinde, e al., 2022, Taiwo, Ola unji & Akomola e, 2022,
Zimme mann-Klemd, e al., 2022). Paye s, including
insu ance p o ide s and go e nmen agencies, de e mine he
inancial sus ainabili y o clinical esea ch by shaping
eimbu semen models. Sponso s und he s udies, se
p io i ies, and o en de ine he scope o inno a ion. Finally,
communi y o ganiza ions including ad ocacy g oups, ai h-
based o ganiza ions, and local nonp o i s se e as b idges o
us , pa icula ly o popula ions his o ically ma ginalized in
esea ch. Toge he , hese s akeholde g oups o m an
ecosys em in which engagemen mus be ca e ully balanced
o achie e clinical esea ch excellence (A iyo, e al., 2023,
Giwah, e al., 2023, Uwai o & Uwai o, 2023).
Engagemen s a egies mus e lec he dis inc oles and
needs o hese s akeholde segmen s. Co-design wo kshops
o e a p ac ical way o in ol e pa ien s, ca egi e s, and
communi y ep esen a i es in shaping s udy p o ocols,
ensu ing ha ec ui men , consen , and ollow-up p ocedu es
align wi h li ed eali ies. Ad iso y boa ds ha include pa ien
ad oca es, clinicians, and egula o s p o ide ongoing inpu
in o ial go e nance, keeping s udies esponsi e and
inclusi e. Town halls ex end engagemen o wide
communi ies, o e ing o ums o open dialogue, us -
building, and educa ion abou esea ch oppo uni ies. Public
commen mechanisms, o en unde u ilized, c ea e channels
o eedback on p o ocols, policies, and dissemina ion
s a egies (E ickson, e al., 2003, Hungbo, Adeyemi & Ajayi,
2019, Uwai o, e al., 2018). These modes o engagemen
ans o m s akeholde s om passi e obse e s in o ac i e
collabo a o s, ein o cing anspa ency and accoun abili y
while en iching ial design and implemen a ion.
Equi y le e s a e essen ial o ensu e ha engagemen
s a egies achie e inclusi i y a he han ein o ce exis ing
“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7302
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
dispa i ies. Cul u al ailo ing o ma e ials and app oaches
ensu es ha ec ui men and e en ion s a egies esona e wi h
di e se popula ions. This may in ol e adap ing image y,
na a i es, and ou each me hods o align wi h cul u al no ms
and alues. Accessibili y measu es expand engagemen o
popula ions wi h disabili ies, low li e acy, o limi ed digi al
li e acy. These measu es include p o iding plain-language
documen s, al e na i e o ma s such as audio o la ge p in ,
and digi al li e acy suppo . Language se ices, including
ansla ion, in e p e a ion, and mul ilingual ma e ials,
disman le linguis ic ba ie s ha o he wise exclude non-
English-speaking popula ions (Adeyemo & Bunmi, 2025,
Bunmi & Adeyemo, 2025, Goba , e al., 2025).
Compensa ion o ime, a el, and ca egi ing bu dens
acknowledges he cos s pa ien s and amilies bea when
pa icipa ing in esea ch, ans o ming engagemen om a
one-sided demand in o a ecip ocal pa ne ship. Toge he ,
hese le e s ope a ionalize he go e nance p inciple o
equi y, ensu ing ha all communi ies ha e ai access o
clinical esea ch oppo uni ies.
The in eg a ion o s akeholde mapping, engagemen
s a egies, and equi y le e s c ea es a eedback loop ha
con inuously imp o es go e nance and ial pe o mance. By
iden i ying all ele an s akeholde s and mapping hei oles,
go e nance amewo ks cla i y esponsibili ies and
expec a ions. By designing ailo ed engagemen s a egies,
ials os e us , esponsi eness, and inclusi i y. By
deploying equi y le e s, ials ac i ely add ess sys emic
ba ie s, ensu ing ha di e se popula ions a e ep esen ed in
bo h pa icipa ion and decision-making. This in eg a ion no
only enhances ec ui men and e en ion bu also s eng hens
he legi imacy and ep oducibili y o ial ou comes
(Adeyemi, e al., 2021, C uz Ri e a, e al., 2021, Giwah, e
al., 2021).
The ou comes o obus s akeholde mapping and
engagemen a e a - eaching. Pa ien s expe ience ials as
collabo a i e endea o s ha espec hei digni y, cul u e, and
needs. Ca egi e s a e suppo ed and acknowledged as c i ical
pa ne s. Si es bene i om clea e communica ion, be e
esou ced p o ocols, and s onge communi y ela ionships.
Regula o s gain con idence ha e hical and scien i ic
s anda ds a e no only being me bu a e being exceeded
h ough anspa en and inclusi e go e nance. Paye s and
sponso s see imp o ed ec ui men and e en ion, educed
delays, and s onge e idence o alue o in es men
(Adegoke, Odugbose & Adeyemi, 2024, Falade, e al., 2024).
Communi ies gain us in he esea ch en e p ise, seeing ha
hei oices a e hea d and hei conce ns add essed.
Collec i ely, hese ou comes ele a e he s anding o clinical
esea ch as a socially esponsi e and scien i ically c edible
endea o .
In conclusion, s akeholde mapping and engagemen s a egy
a e indispensable ools o ad ancing clinical esea ch
excellence. The ca e ul iden i ica ion o s akeholde
segmen s pa ien s, ca egi e s, si es, egula o s, paye s,
sponso s, and communi y o ganiza ions p o ides he
ounda ion o inclusi e go e nance. Engagemen s a egies
such as co-design wo kshops, ad iso y boa ds, own halls,
and public commen p ocesses ensu e ha s akeholde s a e
no pe iphe al bu cen al o ial go e nance. Equi y le e s
such as cul u al ailo ing, accessibili y measu es, language
se ices, and ai compensa ion ensu e ha pa icipa ion is
bo h possible and meaning ul o all popula ions (Hed -
Gau hie , e al., 2017, Lewis, e al., 2014, Pillai, e al., 2018).
By in eg a ing hese elemen s, go e nance amewo ks mo e
beyond compliance o c ea e a uly accoun able, anspa en ,
and pa ien -cen e ed ecosys em. The esul is esea ch ha is
as e , ai e , mo e ep oducible, and mo e us ed, ad ancing
no only scien i ic knowledge bu also public con idence and
social jus ice.
2.5. Ope a ional Enablemen & Technology
Ope a ional enablemen and echnology o m he
in as uc u e ha allows go e nance and s akeholde
engagemen in clinical esea ch o unc ion a scale,
consis en ly, and wi h in eg i y. In mul i-si e ials, especially
in oncology whe e p o ocols a e complex and pa ien
popula ions di e se, he abili y o connec dispa a e sys ems,
moni o p ocesses in eal ime, and manage da a ac oss i s
en i e li ecycle is indispensable. Wi hou hese enabling
echnologies, e en he s onges go e nance p inciples
emain aspi a ional. By ocusing on in e ope abili y, isk-
based moni o ing, cen alized analy ics, and disciplined da a
li ecycle managemen , clinical esea ch ne wo ks can c ea e
sys ems ha a e eliable, e icien , and us wo hy
(Adeyemo, Mba a & Balogun, 2021, Ba nes, e al., 2021, de
Sá Vale, 2021).
In e ope abili y is he i s essen ial pilla . Mul i-si e cance
ials span academic hospi als, communi y p ac ices, and
some imes in e na ional si es, each using di e en elec onic
heal h eco d sys ems and da a cap u e pla o ms. Fas
Heal hca e In e ope abili y Resou ces (FHIR) s anda ds
allow hese dispa a e sys ems o speak a common language,
enabling seamless in eg a ion o clinical and ial da a. EHR
in eg a ion suppo s eal- ime p esc eening o eligibili y,
s eamlining ec ui men while educing he bu den on si e
s a . Elec onic sou ce (eSou ce) da a cap u e educes
duplica ion by allowing in o ma ion collec ed in clinical
wo k lows o low di ec ly in o ial da abases (Beck, e al.,
2020, Cu is, e al., 2020, Uwai o & Fa ou , 2020). Clinical
T ial Managemen Sys ems (CTMS) and Elec onic Da a
Cap u e (EDC) pla o ms p o ide he ope a ional backbone
o scheduling, acking, and alida ing ial ac i i ies.
eConsen pla o ms mode nize in o med consen , enabling
emo e en ollmen and ensu ing compliance h ough
mul imedia comp ehension checks and audi - eady eco ds.
Elec onic pa ien - epo ed ou comes (ePROs) ex end
in e ope abili y o pa ien s hemsel es, allowing hem o
con ibu e da a di ec ly om hei homes h ough digi al
pla o ms. Toge he , hese in e ope able ools c ea e a
connec ed ecosys em in which pa ien , si e, and sponso
“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7303
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
ac i i ies a e in eg a ed and ha monized (Alsulami &
She wood, 2020, Goodle , e al., 2020, Uwai o & John-
Ohimai, 2020).
Risk-based moni o ing builds on his in e ope able
ounda ion by di ec ing o e sigh esou ces whe e hey a e
mos needed. T adi ional moni o ing app oaches ely on
exhaus i e on-si e e iews, which a e slow, cos ly, and o en
ine icien . Risk-based moni o ing shi s he pa adigm by
using cen alized analy ics dashboa ds o iden i y anomalies,
de ia ions, o eme ging isks ac oss si es. By moni o ing
ec ui men eloci y, p o ocol de ia ions, ad e se e en
epo ing, and da a en y imelines in eal ime, go e nance
bodies can de ec issues ea ly and in e ene be o e hey
comp omise ial in eg i y (Ag a io is, e al., 2018, Bha ,
2011, Ellenbe g, Fleming & DeMe s, 2019). Dashboa ds no
only p o ide cen al o e sigh bu also empowe local si es
wi h ac ionable insigh s, encou aging con inuous
imp o emen and accoun abili y. In his way, isk-based
moni o ing ope a ionalizes he go e nance p inciple o
p opo ionali y: o e sigh is a ge ed whe e isk is g ea es ,
educing unnecessa y bu den while s eng hening da a
quali y and pa ien sa e y.
The da a li ecycle ep esen s he hi d c i ical domain o
ope a ional enablemen . In clinical esea ch, da a low is
con inuous and mul i ace ed, om collec ion h ough s o age,
analysis, and epo ing. Lineage acking ensu es ha e e y
da a poin is aceable back o i s o igin, whe he om a
labo a o y esul , an EHR in eg a ion, o an ePRO
submission. This lineage es ablishes con idence in he
au hen ici y o da a and enables egula o s o e i y indings.
Audi ails complemen lineage by logging e e y access,
modi ica ion, and ans e e en . These ails no only comply
wi h egula o y equi emen s such as 21 CFR Pa 11 bu also
p o ide anspa ency ha builds us wi h s akeholde s
(Adeyemi, e al., 2023, Taiwo, Ola unji & Akomola e, 2023).
Valida ion p ocesses a e c i ical a each s ep, ensu ing ha
da a cap u e sys ems, algo i hms, and wo k lows p oduce
accu a e and eliable esul s. Valida ion educes he isk o
sys emic e o s ha could in alida e ial ou comes. Ve sion
con ol p o ides ano he sa egua d, ensu ing ha changes o
p o ocols, da abases, o analy ic ools a e documen ed,
e iewed, and app o ed h ough o mal go e nance
p ocesses. Toge he , hese elemen s o da a li ecycle
managemen p o ec he in eg i y o esea ch indings and
p o ide de ensible e idence in egula o y e iews
(Asampong, e al., 2023, Kaba, e al., 2023, Saesen, Huys &
Lacombe, 2023).
The in eg a ion o in e ope abili y, isk-based moni o ing,
and da a li ecycle managemen c ea es a syne gis ic e ec .
In e ope able sys ems p o ide he in as uc u e o seamless
da a low; isk-based moni o ing ensu es ha o e sigh is
e icien and adap i e; and li ecycle managemen gua an ees
ha da a a e accu a e, secu e, and anspa en om collec ion
o epo ing. This in eg a ion allows go e nance amewo ks
o unc ion as in ended, enabling accoun abili y,
anspa ency, and equi y. Fo pa ien s, hese echnologies
mean ha hei in o ma ion is espec ed, p o ec ed, and used
esponsibly (Essien, e al., 2020, Nicholson, e al., 2020,
Oluyemi, Akin imehin & Akomola e, 2020). Fo
in es iga o s and si e s a , i educes edundancy, cla i ies
esponsibili ies, and p o ides eal- ime eedback o imp o e
pe o mance. Fo sponso s and egula o s, i ensu es ha
e idence is bo h scien i ically obus and ope a ionally
c edible.
The impac o ope a ional enablemen and echnology on
s akeholde engagemen is equally signi ican . Pa ien s
expe ience s eamlined, digi al- iendly p ocesses such as
eConsen and ePROs ha educe bu den and inc ease
accessibili y. Si es bene i om in e ope able sys ems ha
educe manual wo k and om dashboa ds ha highligh
oppo uni ies o imp o emen . Regula o s gain con idence
om audi ails, alida ion epo s, and anspa en da a
lineage, which demons a e compliance and in eg i y.
Communi y o ganiza ions and pa ien ad iso s see e idence
ha go e nance s uc u es p io i ize anspa ency and equi y,
ein o cing us . In his way, ope a ional enablemen does
mo e han suppo e iciency i ac i ely ein o ces he e hical
and social legi imacy o clinical esea ch (Giwah, e al., 2023,
Taiwo, Ola unji & Akomola e, 2023).
In conclusion, ope a ional enablemen and echnology a e he
hidden bu indispensable engines o go e nance and
s akeholde engagemen in clinical esea ch. In e ope abili y
h ough FHIR/EHR in eg a ion, eSou ce, CTMS/EDC,
eConsen , and ePROs ensu es seamless connec i i y ac oss
sys ems and s akeholde s. Risk-based moni o ing and
cen alized analy ics dashboa ds p o ide a ge ed, e icien
o e sigh ha s eng hens bo h quali y and us . Da a
li ecycle managemen , encompassing lineage, audi ails,
alida ion, and e sion con ol, p o ec s he in eg i y o da a
om collec ion h ough epo ing (Hend icks-Fe guson, e
al., 2013, Liu, e al., 2015, Middle on, e al., 2013). Toge he ,
hese domains ans o m go e nance om a se o abs ac
p inciples in o a li ing, unc ioning sys em capable o
deli e ing excellence in clinical esea ch. The esul is a
esea ch ecosys em ha is no only as e and mo e e icien
bu also mo e accoun able, anspa en , and pa ien -cen e ed,
ad ancing bo h scien i ic disco e y and public us .
2.6. E hics, Compliance & Risk Managemen
E hics, compliance, and isk managemen a e no
adminis a i e a e hough s in clinical esea ch; hey a e he
mechanisms by which go e nance and s akeholde
engagemen become c edible, epea able, and wo hy o
public us . Excellence eme ges when e hical in en is
ansla ed in o e i iable p ac ice a he poin s whe e
pa icipan s encoun e he s udy, whe e da a a e c ea ed and
ans o med, and whe e decisions wi h sa e y implica ions a e
made. The i s and mos isible exp ession o his
commi men is in o med consen quali y. Consen mus be a
p ocess, no a documen : i e a i e, comp ehensible, and
accessible (A oba ele, Hungbo & Adeyemi, 2019, Gong, e
“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7304
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
al., 2017, Uwai o, e al., 2019). Mul imedia eConsen wi h
plain-language summa ies, each-back p omp s, and
comp ehension checks helps ensu e unde s anding, while
language se ices and cul u ally ailo ed ma e ials espec
pa icipan s’ con ex s. Accessibili y ea u es sc een eade s,
cap ioned ideos, la ge-p in o audio op ions ex end
inclusion o people wi h disabili ies and low li e acy. Ve sion
con ol wi h ime-s amped audi ails p ese es he chain o
cus ody o consen a i ac s, and e-consen igge s ied o
p o ocol amendmen s o new sa e y in o ma ion main ain
ongoing au onomy. Consen moni o ing spo checks o
comp ehension, na iga o suppo o complex decisions, and
escala ion ou es o ambiguous cases closes he loop
be ween p inciple and p ac ice (Bowman, 2013, Chang, e al.,
2005, E e h, e al., 2017).
P i acy-by-design embeds digni y in o da a handling om
i s con ac o a chi al. Minimal necessa y da a collec ion,
pu pose limi a ion, and con ex -app op ia e e en ion educe
exposu e by de aul . De-iden i ica ion and pseudonymiza ion
gua d agains e-iden i ica ion isk, while enc yp ion in
ansi and a es , g anula ole-based access, leas -p i ilege
pe missions, and con inuous logging cons ain who sees
wha , when, and why. Da a p o ec ion impac assessmen s o
new ools (e.g., wea ables, home senso s, AI p esc eene s)
o ce explici a icula ion o isks and mi iga ions be o e
deploymen (Giwah, e al., 2020, Oluyemi, Akin imehin &
Akomola e, 2020, Özen e & E e h, 2020). Aligning
con ols o HIPAA and, whe e applicable, GDPR s eng hens
c oss-bo de collabo a ions, and inciden esponse playbooks
wi h de ined se e i y ie s, no i ica ion imelines, and
o ensics wo k lows ensu e ha miss eps a e in es iga ed
anspa en ly and emedia ed decisi ely. Vendo con ac s
should encode hese p o ec ions da a p ocessing ag eemen s,
sub-p ocesso disclosu es, b each clauses, and igh - o-audi
p o isions so p i acy expec a ions a e en o ceable, no
aspi a ional.
Con lic o in e es (COI) managemen p o ec s scien i ic
judgmen om bo h inancial and non- inancial p essu es.
S uc u ed, pe iodic disclosu es by in es iga o s, s ee ing
membe s, and ad iso s; independence c i e ia o
DSMB/DMC membe ship; ecusal ules ied o p e-de ined
h esholds; and public summa ies o COI managemen plans
c ea e a de ensible sys em ha acknowledges ela ionships
wi hou allowing hem o dis o design, conduc , o
epo ing. COI e iew should ex end o si e-le el incen i es
and ec ui men con es s, gua ding agains beha io s ha
could bias en ollmen o consen discussions
(Gokulak ishnan & Venka a aman, 2024, Odugbose,
Adegoke & Adeyemi, 2024).
Sa e y o e sigh ope a ionalizes bene icence h ough
disciplined p ac ice. Se ious ad e se e en (SAE) wo k lows
mus be unambiguous: de ec ion a he poin o ca e, apid
case c ea ion in he EDC, medical e iew wi h
causali y/se e i y assessmen , and expedi ed epo ing pe
egula o y imelines. Codi ied esponsibili ies (who is
esponsible, accoun able, consul ed, and in o med) p e en
di usion o du y ac oss busy mul i-si e eams. Unblinding
ules equi e pa icula cla i y. Eme gency unblinding
pa hways mus be as o clinicians ye compa men alized
so ou come assesso s and analys s emain masked; con olled
unblinding o DSMB in e im e iews should use p ede ined
bounda ies and independen s a is icians. Signal de ec ion
complemen s case-le el igilance wi h agg ega e analy ics:
c oss-si e end e iews, s anda dized que ies o ad e se
e en clus e s, and disp opo ionali y o Bayesian moni o ing
app oaches ha can su ace eme ging isks ea ly
(Alemayehu, Mi chell & Nikles, 2018, Ba ge , e al., 2019,
F iedman, e al., 2015). When signals a ise, go e nance
should igge oo -cause analysis, p o ocol cla i ica ions,
a ge ed aining, o , i needed, pauses wi h anspa en
communica ion o pa icipan s and egula o s.
Bias audi s ex end sa e y and e hics in o he socio echnical
subs a e o mode n esea ch. Algo i hmic ools used in
p esc eening, eligibili y ma ching, o isk s a i ica ion mus
be go e ned like any o he in es iga ional echnology. Model
ca ds desc ibing aining da a, pe o mance by subg oup, and
known limi a ions, combined wi h pa i y me ics (e.g.,
ecall/p ecision and alse-posi i e a es by ace, e hnici y,
age, and geog aphy), c ea e isibili y in o di e en ial
pe o mance. Pe iodic e- alida ion wi h local da a and d i
moni o ing ensu es models emain i o pu pose as case-mix
e ol es (Adeyemo, Mba a & Balogun, 2021, Oluyemi,
Akin imehin & Akomola e, 2021). P ocess bias dese es
equal a en ion: appoin men slo s concen a ed du ing wo k
hou s, a el-in ensi e schedules, o English-only ma e ials
can sys ema ically exclude. Audi ing acc ual unnels, sc een-
ail easons, consen declines, and ea ly wi hd awal by
subg oup hen ac ing on he pa e ns con e s measu emen
in o jus ice.
Digi al di ide mi iga ions ansla e equi y om dashboa ds
in o li ed expe ience. De ice loane s, da a s ipends, and Wi-
Fi access poin s a communi y clinics lowe connec i i y
ba ie s. Human suppo s pa ien na iga o s and communi y
heal h wo ke s coach pa icipan s h ough digi al asks, while
p o iding non-digi al al e na i es (pape PROs, elephone
isi s, on-si e consen ) ensu es ha echnology emains an
op ion, no a ga ekeepe . Usabili y es ing wi h pa ien s and
ca egi e s be o e scale-up, plus ongoing helpdesk me ics
(call olume, esolu ion ime, epea issues) eeding
con inuous imp o emen , keep ools humane and wo kable
(Akinbode, e al., 2024, Taiwo, Ola unji & Akomola e,
2024).
Vendo due diligence is a cen al pilla o isk managemen
in an ou sou ced, cloud- i s ecosys em. P e-awa d
assessmen s should e alua e secu i y ce i ica ions (e.g., SOC
2, ISO 27001), secu e SDLC p ac ices, pene a ion es
his o y, up ime SLAs, backup and disas e eco e y, business
con inui y and da a esc ow, wo k o ce backg ound checks,
and p i acy go e nance. Pos -awa d, pe o mance e iews,
con ol a es a ion upda es, and b each d ills alida e ha
“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7311
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
S1415CD) o imp o e cance ca e. BMC Medical
Resea ch Me hodology, 19(1), 119.
40. Ba nes, B., S ansbu y, N., B own, D., Ga son, L.,
Ge a d, G., Piccoli, N., ... & Bu le , P. J. (2021).
Risk-based moni o ing in clinical ials: pas ,
p esen , and u u e. The apeu ic inno a ion &
egula o y science, 55(4), 899-906.
41. Beck, D., Asgha , A., Kenwo hy-Heinige, T.,
Johnson, M. R., Willis, C., Kan o owicz, A. S., ... &
DeLue, C. (2020). Inc easing access o clinical
esea ch using an inno a i e mobile ec ui men
app oach: he (MoRe) concep . Con empo a y
clinical ials communica ions, 19, 100623.
42. Bha adwaj Pa asa am, V. K. (2025). Building
Scalable Regula o y Complian Clinical T ials
Pla o ms o NIH-Sponso ed Resea ch.
43. Bha , A. (2011). Quali y o clinical ials: A mo ing
a ge . Pe spec i es in clinical esea ch, 2(4), 124-
128.
44. Bonaconsa, C., Nampoo hi i, V., Mbamalu, O.,
Dlamini, S., Su end an, S., Singh, S. K., ... &
Cha ani, E. (2024). Men o ship as an o e looked
dimension o esea ch capaci y s eng hening: how
o embed alue-d i en p ac ices in global
heal h. BMJ Global Heal h, 9(1).
45. Bowman, S. (2013). Impac o elec onic heal h
eco d sys ems on in o ma ion in eg i y: quali y and
sa e y implica ions. Pe spec i es in heal h
in o ma ion managemen , 10(Fall), 1c.
46. Boye , A. P., Fai , A. M., Joos en, Y. A., Dolo , R.
J., Williams, N. A., She den, L., ... & Wilkins, C. H.
(2018). A mul ile el app oach o s akeholde
engagemen in he o mula ion o a clinical da a
esea ch ne wo k. Medical Ca e, 56, S22-S26.
47. Bunmi, K. A., & Adeyemo, K. S. A (2025). Re iew
on Ta ge ed D ug De elopmen o B eas Cance
Using Inno a i e Ac i e Pha maceu ical Ing edien s
(APIs).
48. Bu gess, H. E., & Cha away, J. (2021). The
impo ance o men o ship and collabo a ion o
scien i ic capaci y-building and capaci y-sha ing:
pe spec i es o A ican
scien is s. F1000Resea ch, 10.
49. Chang, A., Schy e, P. M., C o eau, R. J., O’Lea y,
D. S., & Loeb, J. M. (2005). The JCAHO pa ien
sa e y e en axonomy: a s anda dized e minology
and classi ica ion schema o nea misses and
ad e se e en s. In e na ional Jou nal o Quali y in
Heal h Ca e, 17(2), 95-105.
50. Chin, R., & Bai u, M. (Eds.). (2011). Global clinical
ials: e ec i e implemen a ion and managemen .
Academic P ess.
51. Co ao, Sal a o e & A co aci, Vincenzo & A none,
Sab ina & Cal o, Luigi & Scaglione, Rosa io &
Be na do, C is o a o & Lagalla, Robe o & Capu i,
Achille & Lica a, Giuseppe. (2008). E idence-
Based Knowledge Managemen : an app oach o
e ec i ely p omo e good heal h-ca e decision-
making in he In o ma ion E a. In e nal and
eme gency medicine. 4. 99-106. 10.1007/s11739-
008-0185-4.
52. C acowski, J. L., Hulo , J. S., Lapo e, S.,
Cha é ia , M., Rous i , M., Deplanque, D., ... &
F ench Socie y o Pha macology and The apeu ics
(SFPT). (2022). Clinical pha macology: Cu en
inno a ions and u u e challenges. Fundamen al &
Clinical Pha macology, 36(3), 456-467.
53. C uz Ri e a, S., To linska, B., Ma s on, E.,
Dennis on, A. K., Oli e , K., Hoa e, S., & Cal e ,
M. J. (2021). Ad ancing UK egula o y science
s a egy in he con ex o global egula ion: a
s akeholde su ey. The apeu ic inno a ion &
egula o y science, 55(4), 646-655.
54. Cu is, N. J., Fos e , J. D., Misko ic, D., B own, C.
S., Hewe , P. J., Abbo , S., ... & F ancis, N. K.
(2020). Associa ion o su gical skill assessmen wi h
clinical ou comes in cance su ge y. JAMA
su ge y, 155(7), 590-598.
55. de Sá Vale, A. M. (2021). Risk Managemen in
Clinical T ials Clinical Resea ch Si es (Mas e 's
hesis, Uni e sidade NOVA de Lisboa (Po ugal)).
56. De oy, C., De oy, C., McLaughlin, R. A., C onin,
C., Cla ke, R., Connolly, R. M., ... & Tangney, M.
(2025). Ope a ional De e minan s o Rec ui men
and Biospecimen Collec ion in T ansla ional
Obse a ional S udies: A Mul i-Si e Compa a i e
Analysis.
57. Diani, C. A., Rock, A., & Moll, P. (2017). An
e alua ion o he e ec i eness o a isk-based
moni o ing app oach implemen ed wi h clinical
ials in ol ing implan able ca diac medical
de ices. Clinical T ials, 14(6), 575-583.
58. Doyen, S., & Dada io, N. B. (2022). 12 plagues o
AI in heal hca e: a p ac ical guide o cu en issues
wi h using machine lea ning in a medical
con ex . F on ie s in digi al heal h, 4, 765406.
59. E e h, T., Saeed, M. E., Mi ghani, E., Alim, A.,
Yassin, Z., Saeed, E., ... & Daak, S. (2017).
In eg a ion o phy ochemicals and phy o he apy in o
cance p ecision medicine. Onco a ge , 8(30),
50284.
60. Ellenbe g, S. S., Fleming, T. R., & DeMe s, D. L.
(2019). Da a moni o ing commi ees in clinical
ials: a p ac ical pe spec i e. John Wiley & Sons.
61. Enna, S. J., & Williams, M. (2009). De ining he
ole o pha macology in he eme ging wo ld o
ansla ional esea ch. In Ad ances in
pha macology (Vol. 57, pp. 1-30). Academic P ess.
62. Epi ano, J. (2023). Be e models o high-s akes
asks (Doc o al disse a ion, Rowan Uni e si y).

“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7312
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
63. E ickson, S. M., Wolco , J., Co igan, J. M., &
Aspden, P. (Eds.). (2003). Pa ien sa e y: achie ing
a new s anda d o ca e.
64. Essien, I. A., Cade , E., Ajayi, J. O., E igha, E. D.,
& Obuse, E. (2020). Cybe isk mi iga ion and
inciden esponse model le e aging ISO 27001 and
NIST o global en e p ises. IRE Jou nals, 3(7),
379–388.
65. Essien, I. A., Cade , E., Ajayi, J. O., E igha, E. D.,
& Obuse, E. (2019). In eg a ed go e nance, isk,
and compliance amewo k o mul i-cloud secu i y
and global egula o y alignmen . IRE Jou nals, 3(3),
215–224.
66. Essien, I. A., Cade , E., Ajayi, J. O., E igha, E. D.,
& Obuse, E. (2020). Regula o y compliance
moni o ing sys em o GDPR, HIPAA, and PCI-
DSS ac oss dis ibu ed cloud a chi ec u es. IRE
Jou nals, 3(12), 409–420.
67. Falade, I. M., Gyampoh, G. K. S., Akpamgbo, E. O.,
Chika, O. C., Obodo, O. R., Okobi, O. E., ... &
Chukwu, V. U. (2024). A comp ehensi e e iew o
e ec i e pa ien sa e y and quali y imp o emen
p og ams in heal hca e acili ies. Medical Resea ch
A chi es, 12(7).
68. Fenlon, D., Chi e s Seymou , K., Okamo o, I.,
Win e , J., Richa dson, A., Adding on-Hall, J., ... &
Fos e , C. (2013). Lessons lea n ec ui ing o a
mul i-si e UK coho s udy o explo e eco e y o
heal h and well-being a e colo ec al cance
(CREW s udy). BMC medical esea ch
me hodology, 13(1), 153.
69. Fneish, F., Schaa schmid , F., & Fo wengel, G.
(2021). Imp o ing isk assessmen in clinical ials:
owa d a sys ema ic isk-based moni o ing
app oach. Cu en The apeu ic Resea ch, 95,
100643.
70. F iedman, L. M., Fu be g, C. D., DeMe s, D. L.,
Reboussin, D. M., & G ange , C. B.
(2015). Fundamen als o clinical ials. sp inge .
71. Giwah, M. L., Nwokediegwu, Z. S., E ukudoh, E.
A., & Gbabo, E. Y. (2020). A esilien in as uc u e
inancing amewo k o enewable ene gy
expansion in Sub-Saha an A ica. IRE Jou nals,
3(12), 382–394.
h ps://www.i ejou nals.com/pape -de ails/1709804
72. Giwah, M. L., Nwokediegwu, Z. S., E ukudoh, E.
A., & Gbabo, E. Y. (2020). A sys ems hinking
model o ene gy policy design in Sub-Saha an
A ica. IRE Jou nals, 3(7), 313–324.
h ps://www.i ejou nals.com/pape -de ails/1709803
73. Giwah, M. L., Nwokediegwu, Z. S., E ukudoh, E.
A., & Gbabo, E. Y. (2020). Sus ainable ene gy
ansi ion amewo k o eme ging economies:
Policy pa hways and implemen a ion gaps.
In e na ional Jou nal o Mul idisciplina y
E olu iona y Resea ch, 1(1), 1–6.
h ps://doi.o g/10.54660/IJMER.2020.1.1.01-06
74. Giwah, M. L., Nwokediegwu, Z. S., E ukudoh, E.
A., & Gbabo, E. Y. (2021). In eg a ed was e- o-
ene gy policy model o u ban sus ainabili y in Wes
A ica. In e na ional Jou nal o Mul idisciplina y
Fu u is ic De elopmen , 2(1), 1–7.
h ps://doi.o g/10.54660/IJMFD.2021.2.1.1-7
75. Giwah, M. L., Nwokediegwu, Z. S., E ukudoh, E.
A., & Gbabo, E. Y. (2021). A s a egic bluep in
model o po e y and unemploymen educ ion
h ough public policy in e en ions. In e na ional
Jou nal o Mul idisciplina y Fu u is ic
De elopmen , 2(2), 1–6.
h ps://doi.o g/10.54660/IJMFD.2021.2.2.1-06
76. Giwah, M. L., Nwokediegwu, Z. S., E ukudoh, E.
A., & Gbabo, E. Y. (2021). Designing a ci cula
economy go e nance amewo k o u ban was e
managemen in A ican megaci ies. In e na ional
Jou nal o Mul idisciplina y E olu iona y Resea ch,
2(2), 20–27.
h ps://doi.o g/10.54660/IJMER.2021.2.2.20-27
77. Giwah, M. L., Nwokediegwu, Z. S., E ukudoh, E.
A., & Gbabo, E. Y. (2023). A mul i-s akeholde
go e nance model o decen alized ene gy access
in u al communi ies. In e na ional Jou nal o
Scien i ic Resea ch in Compu e Science,
Enginee ing and In o ma ion Technology, 10(2),
852–862. h ps://doi.o g/10.32628/CSEIT2342435
78. Giwah, M. L., Nwokediegwu, Z. S., E ukudoh, E.
A., & Gbabo, E. Y. (2023). Designing scalable
ene gy sus ainabili y indices o policy moni o ing
in A ican s a es. In e na ional Jou nal o Ad anced
Mul idisciplina y Resea ch and S udies, 3(6), 2038–
2045.
h ps://doi.o g/10.62225/2583049X.2023.3.6.4713
79. Giwah, M. L., Nwokediegwu, Z. S., E ukudoh, E.
A., & Gbabo, E. Y. (2025). A policy-d i en
in es men eadiness model o sus ainable ene gy
en e p ises in A ica. In e na ional Jou nal o
Eme ging Technology, 10(8), 6249–6258.
h ps://doi.o g/10.47191/e j/ 10i08.18
80. Goba , N., Slack, C., Hannah, S., Salzwedel, J.,
Bladon, G., Bu gos, J. G., ... & on Ha bou, K.
(2025). Be e engagemen , be e e idence:
wo king in pa ne ship wi h pa ien s, he public, and
communi ies in clinical ials wi h in ol emen and
good pa icipa o y p ac ice. The Lance Global
Heal h, 13(4), e716-e731.
81. Gokulak ishnan, D., & Venka a aman, S. (2024).
Ensu ing da a in eg i y: Bes p ac ices and s a egies
in pha maceu ical indus y. In elligen Pha macy.
82. Gong, Y., Kang, H., Wu, X., & Hua, L. (2017).
Enhancing pa ien sa e y e en epo ing. Applied
clinical in o ma ics, 8(03), 893-909.
“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7313
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
83. Goodle , D., Hung, A., Fe iozzi, A., Lu, H.,
Bekelman, J. E., & Mullins, C. D. (2020). Si e
engagemen o mul i-si e clinical
ials. Con empo a y Clinical T ials
Communica ions, 19, 100608.
84. Ha e lach, T., Ecka d , J. N., Wal e , W., Maschek,
S., Ka he , J. N., Pohlkamp, C., & Middeke, J. M.
(2025, June). AML diagnos ics in he 21s cen u y:
Use o AI. In Semina s in Hema ology. WB
Saunde s.
85. Hamil on, A. B., & Yano, E. M. (2017). The
impo ance o symbolic and engaged pa icipa ion in
e idence-based quali y imp o emen in a complex
in eg a ed heal hca e sys em: esponse o “The
science o s akeholde engagemen in
esea ch”. T ansla ional beha io al medicine, 7(3),
492-494.
86. Haw, J. S., Gala iz, K. I., S aus, A. N., Kowalski,
A. J., Magee, M. J., Webe , M. B., ... & Ali, M. K.
(2017). Long- e m sus ainabili y o diabe es
p e en ion app oaches: a sys ema ic e iew and
me a-analysis o andomized clinical ials. JAMA
in e nal medicine, 177(12), 1808-1817.
87. Hed -Gau hie , B. L., Chilengi, R., Jackson, E.,
Michel, C., Napua, M., Odhiambo, J., & Bawah, A.
(2017). Resea ch capaci y building in eg a ed in o
PHIT p ojec s: le e aging esea ch and esea ch
unding o build na ional capaci y. BMC heal h
se ices esea ch, 17(Suppl 3), 825.
88. Hend icks-Fe guson, V. L., Che en, B. O., Bu ns,
D. S., Doche y, S. L., Phillips-Salimi, C. R., Roll,
L., ... & Haase, J. E. (2013). Rec ui men s a egies
and a es o a mul i-si e beha io al in e en ion o
adolescen s and young adul s wi h cance . Jou nal o
Pedia ic Heal h Ca e, 27(6), 434-442.
89. Higa, A., Yagi, M., Hayashi, K., Kosako, M., &
Akiho, H. (2020). Risk-based moni o ing app oach
o ensu e he quali y o clinical s udy da a and enable
e ec i e moni o ing. The apeu ic Inno a ion &
Regula o y Science, 54(1), 139-143.
90. Ho mann, B., & Rohe, J. (2010). Pa ien sa e y and
e o managemen : wha causes ad e se e en s and
how can hey be p e en ed?. Deu sches A z ebla
In e na ional, 107(6), 92.
91. Hopkins, J., Bu ns, E., & Eden, T. (2013).
In e na ional winning pa ne ships: an e ec i e
me hod o imp o ing diagnosis, ea men and ca e
o child en wi h cance in low-middle income
coun ies. Jou nal o Cance Policy, 1(1-2), e8-e19.
92. h ps://doi.o g/10.51594/gjab . 3i8.152
93. Hungbo, A. Q., & Adeyemi, C. (2019). Labo a o y
Sa e y and Diagnos ic Reliabili y F amewo k o
Resou ce-Cons ained Blood Bank Ope a ions.
94. Hungbo, A. Q., & Adeyemi, C. (2024). Communi y-
Based T aining Model o P ac ical Nu ses in
Ma e nal and Child Heal h Clinics.
95. Hungbo, A. Q., Adeyemi, C., & Ajayi, O. O. (2019).
Powe BI-Based Clinical Decision Suppo Sys em
o E idence-Based Nu se Decision-Making.
96. Hungbo, A. Q., Adeyemi, C., & Ajayi, O. O. (2023).
Ope a ional Skill T ans e Model o Eme gency
Nu sing om High-Risk Indus ial En i onmen s.
97. Hu ley, C., Shiely, F., Powe , J., Cla ke, M.,
Eus ace, J. A., Flanagan, E., & Kea ney, P. M.
(2016). Risk based moni o ing (RBM) ools o
clinical ials: a sys ema ic e iew. Con empo a y
clinical ials, 51, 15-27.
98. Isa, A. K., & Adeyemo, I. (2025, July 4). Xylazine
and en anyl co-in ol emen in U.S. o e dose
dea hs: A sys ema ic e iew o public heal h ends,
mechanisms, and in e en ion gaps. Jou nal o
F on ie s in Mul idisciplina y Resea ch, 6(2), 96–
102. Jou nal o F on ie s in Mul idisciplina y
Resea ch.
99. Johnson, M. R., Kenwo hy-Heinige, T., Beck, D. J.,
Asgha , A., B oussa d, E. B., B a che , K., ... &
Plane a, B. M. (2018). Resea ch si e men o ing: A
no el app oach o imp o ing s udy
ec ui men . Con empo a y clinical ials
communica ions, 9, 172-177.
100. K Gohagan, J., B ien, B., A Hasson, M., D Umbel,
K., B idgeman, B., S K ame , B., ... & C P o ok, P.
(2015). Comp ehensi e Quali y Managemen
(CQM) in he PLCO T ial. Re iews on Recen
Clinical T ials, 10(3), 223-232.
101. Kaba, M., Bi hanu, Z., Villalobos, N. V. F., Oso io,
L., Echa a ia, M. I., Be he, D. F., ... & Ab aha, Y.
G. (2023). Heal h esea ch men o ship in low-and
middle-income coun ies: a scoping e iew. JBI
e idence syn hesis, 21(10), 1912-1970.
102. Kabi , M., Rana, M. R. H., & Debna h, A. (2024).
The Role o Quali y Assu ance in Accele a ing
Pha maceu ical Resea ch and De elopmen :
S a egies o Ensu ing Regula o y Compliance and
P oduc In eg i y. In eg a i e Biomedical
Resea ch, 8(12), 1-11.
103. Ken , J., Tho n on, M., Fong, A., Hall, E.,
Fi zgibbons, S., & Sa a, J. (2020). Acu e p o ide
s ess in high s akes medical ca e: implica ions o
auma su geons. Jou nal o T auma and Acu e Ca e
Su ge y, 88(3), 440-445.
104. Kingsley, O., Akomola e, O. O., & Akin imehin, O.
O. (2020). A Communi y-Based Heal h and
Nu i ion In e en ion F amewo k o C isis-
A ec ed Regions. Iconic Resea ch and Enginee ing
Jou nals, 3(8), 311-333.
105. Kunle, A. A., & Taiwo, K. A. (2025). P edic i e
Modeling o Heal hca e Cos Analysis in he Uni ed
“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7314
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
S a es: A Comp ehensi e Re iew and Fu u e
Di ec ions.
106. Lakshmi P iya, V. P., & De i, M. (2025). Po en ial
o in eg a ing phy ochemicals wi h s anda d
ea men s o enhanced ou comes in TBI. B ain
Inju y, 1-17.
107. Lewis, S., Bloom, J., Rice, J., Naeim, A., & Sho ell,
S. (2014). Using eams o implemen pe sonalized
heal h ca e ac oss a mul i-si e b eas cance ne wo k.
In Popula ion Heal h Managemen in Heal h Ca e
O ganiza ions (pp. 71-94). Eme ald G oup
Publishing Limi ed.
108. Liu, Y., Nandi a, M. D., Shanka , L. K., Kauczo , H.
U., T a nig, S., Colle e, S., & Chi i, A. (2015). A
isk managemen app oach o imaging bioma ke -
d i en clinical ials in oncology. The Lance
Oncology, 16(16), e622-e628.
109. Lysiuk, R. (2024). The Role o Biochemicals and
Phy omedicine in Complemen a y Medicine and
Mode n D ug Disco e y: B idging T adi ion and
Inno a ion. Jou nal o Biochemicals and
Phy omedicine, 3(2), 1-3.
110. Mace ield, R. C., Beswick, A. D., Blazeby, J. M., &
Lane, J. A. (2013). A sys ema ic e iew o on-si e
moni o ing me hods o heal h-ca e andomised
con olled ials. Clinical T ials, 10(1), 104-124.
111. Ma ques, L., Cos a, B., Pe ei a, M., Sil a, A.,
San os, J., Saldanha, L., ... & Vale, N. (2024).
Ad ancing p ecision medicine: a e iew o
inno a i e in silico app oaches o d ug
de elopmen , clinical pha macology and
pe sonalized heal hca e. Pha maceu ics, 16(3), 332.
112. Middle on, B., Bloom osen, M., Den e, M. A.,
Hashma , B., Koppel, R., O e hage, J. M., ... &
Zhang, J. (2013). Enhancing pa ien sa e y and
quali y o ca e by imp o ing he usabili y o
elec onic heal h eco d sys ems: ecommenda ions
om AMIA. Jou nal o he Ame ican Medical
In o ma ics Associa ion, 20(e1), e2-e8.
113. Min, X., Jones, C., Logan, B., Campean, M.,
Wekhyan, B., Dasana, C., ... & Yu, F. (2025).
Genome-Wide Iden i ica ion and Analysis o
Al e na i e Splicing in Aspe gillus nige .
Compu a ional Molecula Biology, 15.
114. Mugo, C., Njuguna, I., Ndua i, M., Omondi, V.,
O ieno, V., Nyapa a, F., ... & Wagne , A. D. (2020).
F om esea ch o in e na ional scale-up: s akeholde
engagemen essen ial in success ul design,
e alua ion and implemen a ion o paedia ic HIV
es ing in e en ion. Heal h Policy and
Planning, 35(9), 1180-1187.
115. Muneses, S. A. D. (2025). The Global Clinical T ials
Ecosys em: A C i ical E alua ion and Fu u e
Ou look.
116. Musyuni, P., Sha ma, R., & Agga wal, G. (2023).
Op imizing d ug disco e y: An oppo uni y and
applica ion wi h e e se ansla ional
esea ch. Heal h Sciences Re iew, 6, 100074.
117. Muyassa o a, M. M., & Bol aboye , S. E. (2025).
S a egies Fo Imp o ing Pa ien Sa e y In
Hospi als. Wes e n Eu opean Jou nal o Medicine
and Medical Science, 3(01), 1-8.
118. Nchinda, T. C. (2002). Resea ch capaci y
s eng hening in he Sou h. Social science &
medicine, 54(11), 1699-1711.
119. Nicholson, K., Ganann, R., Bookey-Basse , S.,
Bai d, L. G., Ga ne , A., Ma shall, Z., ... & S ewa ,
M. (2020). Capaci y building and men o ship among
pan-Canadian ea ly ca ee esea che s in
communi y-based p ima y heal h ca e. P ima y
heal h ca e esea ch & de elopmen , 21, e3.
120. Obodozie, O. O. (2012). Pha macokine ics and d ug
in e ac ions o he bal medicines: A missing c i ical
s ep in he phy omedicine/d ug de elopmen
p ocess. Reading in ad anced pha macokine ics-
heo y, me hods, and applica ions. C oa ia: InTech,
127-56.
121. Oboh, A., Uwai o, F., Gab iel, O. J., Uwai o, A. O.,
Ajayi, S. A. O., & Ukoba, J. U. (2024). Mul i-O gan
oxici y o o ganophospha e compounds:
hepa o oxic, neph o oxic, and ca dio oxic
e ec s. In e na ional Medical Science Resea ch
Jou nal, 4(8), 797-805.
122. Odugbose, T., Adegoke, B. O., & Adeyemi, C.
(2024). Leade ship in global heal h: Na iga ing
challenges and oppo uni ies o impac ul ou comes
in A ica and S i lanka. In e na ional Jou nal o
Managemen & En ep eneu ship Resea ch, 6(4),
1190-1199.
123. Odugbose, T., Adegoke, B. O., & Adeyemi, C.
(2024). Re iew o inno a i e app oaches o men al
heal h ele he apy: Access and
e ec i eness. In e na ional Medical Science
Resea ch Jou nal, 4(4), 458-469.
124. Oladeinde, B. H., Olaniyan, M. F., Muhibi, M. A.,
Uwai o, F., Richa d, O., Omabe, N. O., ... & Ozolua,
O. P. (2022). Associa ion be ween ABO and RH
blood g oups and hepa i is B i us in ec ion among
young Nige ian adul s. Jou nal o p e en i e
medicine and hygiene, 63(1), E109.
125. Oladeinde, B. H., Olaniyan, M. F., Muhibi, M. A.,
Uwai o, F., Richa d, O., Omabe, N. O., ... & Ozolua,
O. P. (2022). Associa ion be ween ABO and RH
blood g oups and hepa i is B i us in ec ion among
young Nige ian adul s. Jou nal o p e en i e
medicine and hygiene, 63(1), E109.
126. Oladipo, D. A., Akin imehin, O. O., & Samuel, F.
O. (2025). Die a y Di e si y and Food Insecu i y
among Medical S uden s o he Uni e si y o
“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7315
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
Ibadan: A C oss-sec ional S udy. Wes A ican
jou nal o medicine, 42(3), 215-224.
127. Olaniyan, M. F., Ale, S. A., & Uwai o, F. (2019).
Raw cucumbe (Cucumis sa i us) ui juice as
possible i s -aid an ido e in d ug-induced
oxici y. Recen Ad Biol Med, 5(2019), 10171.
128. Olaniyan, M. F., Ojedi an, T. B., Uwai o, F., &
Azeez, M. M. (2018). Hos immune esponses o
mono-in ec ions o Plasmodium spp., hepa i is B
i us, and Mycobac e ium ube culosis as e idenced
by blood complemen 3, complemen 5, umo
nec osis ac o -α and in e leukin-10: Hos immune
esponses o mono-in ec ions o Plasmodium spp.,
hepa i is B i us, and Mycobac e ium
ube culosis. Communi y Acqui ed In ec ion, 5.
129. Olaniyan, M. F., Omosigho, P. O., Uwai o, F.,
Olaniyan, T. B., Adepoju, A. L., & Odegbemi, O. B.
(2025). Immunogene ic a ia ions in HIV se o ypes
in pa ien s a ending mili a y hospi al, Wa i,
Nige ia. Egyp ian Jou nal o Medical Human
Gene ics, 26(1), 56.
130. Olaniyan, M. F., Uwai o, F., & Ojedi an, T. B.
(2019). Possible i al immunochemical s a us o
child en wi h ele a ed blood ib inogen in some
he bal homes and hospi als in
Nige ia. En i onmen al Disease, 4(3), 81-86.
131. Olaniyan, M. F., Uwai o, F., & Olaniyan, T. B.
(2022). An i-In lamma o y, i al eplica ion
supp ession and hepa op o ec i e ac i i ies o bi e
kola-lime juice,-honey mix u e in HBeAg
se oposi i e pa ien s. Ma ix Science Pha ma, 6(2),
41-45.
132. Oluyemi, M. D., Akin imehin, O. O., & Akomola e,
O. O. (2020). Designing a C oss-Func ional
F amewo k o Compliance wi h Heal h Da a
P o ec ion Laws in Mul iju isdic ional Heal hca e
Se ings. Iconic Resea ch and Enginee ing
Jou nals, 4(4), 279-296.
133. Oluyemi, M. D., Akin imehin, O. O., & Akomola e,
O. O. (2020). De eloping a F amewo k o Da a
Quali y Assu ance in Elec onic Heal h Reco d
(EHR) Sys ems in Heal hca e Ins i u ions. Iconic
Resea ch and Enginee ing Jou nals, 3(12), 335-349.
134. Oluyemi, M. D., Akin imehin, O. O., & Akomola e,
O. O. (2020). F amewo k o Le e aging Heal h
In o ma ion Sys ems in Add essing Subs ance
Abuse Among Unde se ed Popula ions. Iconic
Resea ch and Enginee ing Jou nals, 4(2), 212-226.
135. Oluyemi, M. D., Akin imehin, O. O., & Akomola e,
O. O. (2020). Modeling Heal h In o ma ion
Go e nance P ac ices o Imp o ed Clinical
Decision-Making in U ban Hospi als. Iconic
Resea ch and Enginee ing Jou nals, 3(9), 350-362.
136. Oluyemi, M. D., Akin imehin, O. O., & Akomola e,
O. O. (2021). A S a egic F amewo k o Aligning
Clinical Go e nance and Heal h In o ma ion
Managemen in Mul i-Special y Hospi als. Jou nal
o F on ie s in Mul idisciplina y Resea ch, 2(1),
175-184.
137. Oluyemi, M. D., Akin imehin, O. O., & Akomola e,
O. O. (2021). De eloping a Risk-Based Su eillance
Model o Ensu ing Pa ien Reco d Accu acy in
High-Volume Hospi als. Jou nal o F on ie s in
Mul idisciplina y Resea ch, 2(1), 196-204.
138. Onyeji, G. N., & Sanusi, R. A. (2018). Die quali y
o women o childbea ing age in Sou h-eas
Nige ia. Nu i ion & Food Science, 48(2), 348-364.
139. Osi owokan, A. S., & Adukpo, T. K. (2024). The
impo ance o quali y assu ance in clinical ials:
Ensu ing da a in eg i y and egula o y compliance in
he US pha maceu ical indus y.
140. Ozdemi , O. (2024). Explainable AI (XAI) in
Heal hca e: B idging he Gap be ween Accu acy
and In e p e abili y. Jou nal o Science, Technology
and Enginee ing Resea ch, 1(1), 32-44.
141. Özen e , N., & E e h, T. (2020). In eg a ion o
Phy ochemicals and Phy o he apy in o Cance
P ecision Medicine. In App oaching Complex
Diseases: Ne wo k-Based Pha macology and
Sys ems App oach in Bio-Medicine (pp. 355-392).
Cham: Sp inge In e na ional Publishing.
142. Paul, A. L. (2025). B idging he Black Box:
Enhancing Explainable AI in High-S akes Decision-
Making Sys ems.
143. Pe e , I. (2025). AI-Powe ed Decision Suppo
Sys ems Fo Agile Go e nance In
Biopha maceu ical Po olios.
144. Pe ko ic, J., Riddle, A., Akl, E. A., Khabsa, J.,
Ly yn, L., A we e, P., ... & Tugwell, P. (2020).
P o ocol o he de elopmen o guidance o
s akeholde engagemen in heal h and heal hca e
guideline de elopmen and
implemen a ion. Sys ema ic e iews, 9(1), 21.
145. Pie obon, R., Machia elli, A., Rod igues, L. P.,
Ag ey, A., Nkeangnyi, L. Y., Zechia, G., ... &
Spo eDa a, O. U. (2025). Risk-Based Moni o ing: A
S a egic App oach o Enhancing Da a Quali y in
Clinical T ials.
146. Pillai, G., Chibale, K., Cons able, E. C., Kelle , A.
N., Gu ie ez, M. M., Mi za, F., ... & Kaise , H. J.
(2018). The Nex Gene a ion Scien is p og am:
capaci y-building o u u e scien i ic leade s in
low-and middle-income coun ies. BMC Medical
Educa ion, 18(1), 233.
147. Ponka, D., Co man, M., F ase -Ba clay, K. E.,
Fo ie , R. D., Howe, A., Kidd, M., ... & Goodyea -
Smi h, F. (2020). Fos e ing global p ima y ca e
esea ch: a capaci y-building app oach. BMJ global
heal h, 5(7), e002470.
“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7316
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
148. P asanna, B., Ko hapalli, P., & Vasan han, M.
(2024). The ole o quali y assu ance in clinical
ials: Sa egua ding da a in eg i y and
compliance. Cu eus, 16(8).
149. Rosemann, A. (2017). Challenges o in e na ional
s em cell clinical ials in coun ies wi h di e ging
egula ions. In Sa e y, e hics and egula ions (pp.
301-319). Cham: Sp inge In e na ional Publishing.
150. Roses, A. D. (2008). Pha macogene ics in d ug
disco e y and de elopmen : a ansla ional
pe spec i e. Na u e e iews D ug disco e y, 7(10),
807-817.
151. Roso sky, A. S., & Vo hees, D. J. (2023). B inging
mul isec o al and mul idisciplina y s akeholde s
oge he o op imize en i onmen al heal h esea ch.
GeoHeal h, 7(2), e2022GH000746.
152. Saesen, R., Huys, I., & Lacombe, D. (2023).
Balancing Inno a ion Wi h Op imiza ion in
Oncology: A enues o B idging he Cance
Clinical Resea ch Gap.
153. Sagay, I., Akomola e, O. O., Taiwo, A. E.,
Bola inwa, T., & Opa ah, S. (2024). Ha nessing AI
o Ea ly De ec ion o Age-Rela ed Diseases: A
Re iew o Heal h Da a Analy ics App oaches.
154. Sanka , B. S., Gilliland, D., Rincon, J., He mjakob,
H., Yan, Y., Adam, I., ... & Ping, P. (2024). Building
an e hical and us wo hy biomedical AI ecosys em
o he ansla ional and clinical in eg a ion o
ounda ion models. Bioenginee ing, 11(10), 984.
155. Selby, J. V., G ossman, C., Zi kle, M., & Ba bash,
S. (2018). Mul is akeholde engagemen in
PCORne , he na ional pa ien -cen e ed clinical
esea ch ne wo k. Medical Ca e, 56, S4-S5.
156. Se e i, I., Shaw-Saliba, K., Dodd, L. E., Dewa , R.
L., La e du e, S., B own, S., ... & Hunsbe ge , S.
(2022). Design o an obse a ional mul i-coun y
coho s udy o assess immunogenici y o mul iple
accine pla o ms (InVITE). Plos one, 17(9),
e0273914.
157. Shyu , L. F., & Yang, N. S. (2008). Me abolomics
o phy omedicine esea ch and d ug
de elopmen . Cu en opinion in chemical
biology, 12(1), 66-71.
158. Smi h, L., Tan, A., S ephens, J. D., Hible , D., &
Du y, S. A. (2019). O e coming challenges in
mul isi e ials. Nu sing esea ch, 68(3), 227-236.
159. Squi es, J. E., Hu chinson, A. M., Coughlin, M.,
Bashi , K., Cu an, J., G imshaw, J. M., ... &
G aham, I. D. (2021). S akeholde pe spec i es o
a ibu es and ea u es o con ex ele an o
knowledge ansla ion in heal h se ings: a mul i-
coun y analysis. In e na ional Jou nal o Heal h
Policy and Managemen , 11(8), 1373.
160. S i as a a, P., Kuma i, B. M., Rajeswa i, S. U.,
Meena, J., Gangopadhyay, S., Gup a, S., ... &
Packi isamy, S. (2024). A comp ehensi e e iew o
ad ancemen s in pha macology and d ug
disco e y. Jou nal o Expe imen al Zoology
India, 27(2).
161. Taiwo, K. A. 2025, AI-powe ed c edi isk
assessmen and algo i hmic ai ness in digi al
lending: A comp ehensi e analysis o he Uni ed
S a es digi al inance landscape. Wo ld Jou nal o
Ad anced Resea ch and Re iews, 2025, 26(03),
1446-1460.
h ps://doi.o g/10.30574/wja .2025.26.3.2291.
162. Taiwo, K. A. 2015: AI in popula ion heal h: Scaling
p e en i e models o age- ela ed diseases in he
Uni ed S a es. In e na ional Jou nal o Science and
Resea ch A chi e, 2025, 16(01), 1240-1260.
h ps://doi.o g/10.30574/ijs a.2025.16.1.2015
163. Taiwo, K. A., Akinbode, A. K., and Uchenna, E.
2024, Ad anced A/B Tes ing and Causal In e ence
o AI-D i en Digi al Pla o ms: A Comp ehensi e
F amewo k o US Digi al Ma ke s. In e na ional
Jou nal o Compu e Applica ions Technology and
Resea ch, 2024, 13(6), 24-46.
h ps://ijca .com/ olume13/issue6
164. Taiwo, K. A., and Akinbode, A. K. 2024,
"In elligen Supply Chain Op imiza ion h ough IoT
Analy ics and P edic i e AI: A Comp ehensi e
Analysis o US Ma ke Implemen a ion." Volume. 2
Issue. 3, Ma ch - 2024 In e na ional Jou nal o
Mode n Science and Resea ch Technology
(IJMSRT), www.ijms .com. PP :- 1-22.
165. Taiwo, K. A., and Busa i, I. O., 2025, Le e aging
AI-D i en P edic i e Analy ics o Enhance
Cogni i e Assessmen and Ea ly In e en ion in
STEM Lea ning and Heal h Ou comes. Wo ld
Jou nal o Ad anced Resea ch and Re iews, 2025,
27(01), 2658-2671. A icle DOI:
h ps://doi.o g/10.30574/wja .2025.27.1.2548
166. Taiwo, K. A., Ola unji, G. I., & Akomola e, O. O.
(2022). Clima e Change and i s Impac on he
Sp ead o In ec ious Diseases: A Case S udy
App oach. In e na ional Jou nal o Scien i ic
Resea ch in Compu e Science, Enginee ing and
In o ma ion Technology. 2022, 8(5), 566-595
167. Taiwo, K. A., Ola unji, G. I., & Akomola e, O. O.
(2023). An In e ac i e Tool o Moni o ing Heal h
Dispa i ies Ac oss Coun ies in he U.S.
Gyanshau yam, In e na ional Scien i ic Re e eed
Resea ch Jou nal. 2023, 6(4), 308-337
168. Taiwo, K. A., Ola unji, G. I., & Akomola e, O. O.
(2023). An In e ac i e Tool o Moni o ing Heal h
Dispa i ies Ac oss Coun ies in he US.
169. Taiwo, K. A., Ola unji, G. I., & Akomola e, O. O.
(2024). Using Clus e ing o Segmen High-Risk
Pa ien s o Tailo ed In e en ions.

“Go e nance and S akeholde Engagemen as Tools o Ad ancing Clinical Resea ch Excellence”
7317
Issue 10 Oc obe 2025ETJ Volume 10 ,
1
Chisom Ezeanochie
170. Taiwo, K. A., Ola unji, G. I., & Akomola e, O. O.
(2025). Fo ecas ing hospi al esou ce demand using
ime se ies and machine lea ning models. Gul
Jou nal o Ad ance Business Resea ch, 2025, 3(8),
1107-1142
171. Taiwo, K. A., Pe e , K. O., Baba uyi. P., Aigbogun.
H. E., & Ogi i. K. 2025, Reducing Diagnos ic
Delays in Ch onic Illnesses Using P edic i e
Analy ics: A F amewo k o Heal hca e
T ans o ma ion in he Uni ed S a es. IOSR Jou nal
o Nu sing and Heal h Science, 2025, 14(4), 39-52
172. Te ano a, N., Venka ak ishnan, K., & Benincosa,
L. J. (2021). Applica ion o machine lea ning in
ansla ional medicine: cu en s a us and u u e
oppo uni ies. The AAPS Jou nal, 23(4), 74.
173. Thom o d, N. E., Dzobo, K., Chimusa, E., And ae-
Ma obela, K., Chi iku e, S., Wonkam, A., &
Danda a, C. (2018). Pe sonalized he bal medicine?
A oadmap o con e gence o he bal and p ecision
medicine bioma ke inno a ions. OMICS: A
Jou nal o In eg a i e Biology, 22(6), 375-391.
174. Tho nic o , G., Coope , S., Bo el, T. V., Kakuma,
R., & Lund, C. (2012). Capaci y building in global
men al heal h esea ch. Ha a d e iew o
psychia y, 20(1), 13-24.
175. Timme mans, C., Vene , D., & Bu zykowski, T.
(2016). Da a-d i en isk iden i ica ion in phase III
clinical ials using cen al s a is ical
moni o ing. In e na ional jou nal o clinical
oncology, 21(1), 38-45.
176. Timmis, J. K. (2021). Imp o ing heal hca e
inno a ion and decision making by ex ensi e
s akeholde in ol emen .
177. Ul ich-Me zenich, G., Panek, D., Zei le , H.,
Wagne , H., & Ve e , H. (2009). New pe spec i es
o syne gy esea ch wi h he “omic”-
echnologies. Phy omedicine, 16(6-7), 495-508.
178. Uwai o, F. (2020). E alua ion o weigh and
appe i e o adul wis a a s supplemen ed wi h
e hanolic lea ex ac o Mo inga
olei e a. Biomedical and Bio echnology Resea ch
Jou nal (BBRJ), 4(2), 137-140.
179. Uwai o, F., & Fa ou , J. O. (2020). Assessmen o
he his ological changes o he hea and kidneys
induced by be be ine in adul albino wis a
a s. Ma ix Science Medica, 4(3), 70-73.
180. Uwai o, F., & John-Ohimai, F. (2020). Body weigh ,
o gan weigh , and appe i e e alua ion o adul albino
Wis a a s ea ed wi h be be ine. In e na ional
Jou nal o Heal h & Allied Sciences, 9(4), 329-329.
181. Uwai o, F., & John-Ohimai, F. (2020). Dange s o
o ganophospha e pes icide exposu e o human
heal h. Ma ix Science Medica, 4(2), 27-31.
182. Uwai o, F., & Uwai o, A. O. (2023). B idging he
gap in alcohol use diso de ea men : in eg a ing
psychological, physical, and a i icial in elligence
in e en ions. In e na ional Jou nal o Applied
Resea ch in Social Sciences, 5(4), 1-9.
183. Uwai o, F., Ngoke e, A., Obi, E., Olaniyan, M., &
Bankole, O. (2019). His ological and biochemical
changes induced by e hanolic lea ex ac o
Mo inga olei e a in he li e and lungs o adul
wis a a s. Biomedical and Bio echnology Resea ch
Jou nal (BBRJ), 3(1), 57-60.
184. Uwai o, F., Obi, E., Ngoke e, A., Olaniyan, M. F.,
Oladeinde, B. H., & Mudiaga, A. (2018).
His ological and biochemical changes induced by
e hanolic lea ex ac o Mo inga olei e a in he hea
and kidneys o adul wis a a s. Imam Jou nal o
Applied Sciences, 3(2), 59-62.
185. Wa en, D. (2025). De elopmen and Op imisa ion
o O ganisa ional S uc u es o Suppo High-
Quali y Clinical Resea ch in Academic Medical
Cen es in Ke ala.
186. Wilkins, C. H., Edwa ds, T. L., S oud, M.,
Kennedy, N., Je ome, R. N., Law ence, C. E., ... &
Ha is, P. A. (2021). The Rec ui men Inno a ion
Cen e : de eloping no el, pe son-cen e ed
s a egies o clinical ial ec ui men and
e en ion. Jou nal o Clinical and T ansla ional
Science, 5(1), e194.
187. Will, Y., McDu ie, J. E., Olaha ski, A. J., & Je y,
B. D. (Eds.). (2016). D ug disco e y oxicology:
om a ge assessmen o ansla ional bioma ke s.
John Wiley & Sons.
188. Zhang, W., Zeng, Y., Jiao, M., Ye, C., Li, Y., Liu,
C., & Wang, J. (2023). In eg a ion o high-
h oughpu omics echnologies in medicinal plan
esea ch: The new e a o na u al d ug
disco e y. F on ie s in Plan Science, 14, 1073848.
189. Zhang, X., Chan, F. T., Yan, C., & Bose, I. (2022).
Towa ds isk-awa e a i icial in elligence and
machine lea ning sys ems: An o e iew. Decision
Suppo Sys ems, 159, 113800.
190. Zimme mann-Klemd, A. M., Reinha d , J. K.,
Winke , M., & G ündemann, C. (2022).
Phy o he apy in in eg a i e oncology an upda e o
p omising ea men op ions. Molecules, 27(10),
3209.
191. Zineh, I., & Woodcock, J. (2013). Clinical
pha macology and he ca alysis o egula o y
science: oppo uni ies o he ad ancemen o d ug
de elopmen and e alua ion. Clinical
Pha macology & The apeu ics, 93(6), 515-525.